The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance

Go back to The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance

The Oncology Institute, Inc. (TOI) Misses Q3 EPS by 1c; Offers FY22 Revenue Guidance

November 9, 2022 4:40 PM EST

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q3 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $65 million versus the consensus estimate of $68.91 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2022 revenue of $245-250... More